Replication-Deficient JYNNEOS Recommended for Orthopoxvirus

TUESDAY, May 31, 2022 (HealthDay News) -- The replication-deficient Vaccinia virus vaccine (JYNNEOS) is recommended over the replication-competent Vaccinia virus vaccine ACAM2000 for individuals with occupational exposure to orthopoxvirus, according to research published in the May 27 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Noting that occupational exposure to orthopoxvirus infections can be serious and that the American Committee on Immunization Practices (ACIP) has continued to recommend preexposure vaccination for these persons since 1980, Agam K. Rao, M.D., from the CDC in Atlanta, and colleagues reviewed the current recommendations on preexposure vaccination.
The authors note that in 2015, ACIP recommended the ACAM2000 vaccine, which was the only available orthopoxvirus vaccine. Evidence was considered during 2020 to 2021 for JYNNEOS as an alternative to ACAM2000. Based on the evidence, JYNNEOS was found to provide a small increase in disease prevention compared with ACAM2000 for the primary series. In addition, fewer serious adverse events occurred following the JYNNEOS versus ACAM2000 primary series, and there were fewer events of myopericarditis after vaccination with JYNNEOS. A small increase in disease prevention was found after a JYNNEOS booster versus the primary series only, and fewer serious adverse events occurred after a booster administered following completion of the primary series. Based on these findings, ACIP voted unanimously in favor of JYNNEOS as an alternative to ACAM2000 in November 2021, for both primary vaccination and booster doses.
"JYNNEOS involves a replication-deficient virus and has fewer contraindications, no risk for inadvertent inoculation and autoinoculation, and is associated with fewer serious adverse events compared with ACAM2000," the authors write.
Two authors disclosed financial ties to companies that manufacture vaccines.
Related Posts
Retiran más de 400 refrigerios y sándwiches por Listeria
MARTES, 7 de febrero de 2023 (HealthDay News) -- Una variedad de sándwiches,...
Wegovy y Saxenda ayudan a las personas a perder el peso que recuperaron tras una cirugía para la obesidad
LUNES, 5 de junio de 2023 (HealthDay News) -- Cuando las personas recuperaban...
Understanding How COVID Can Trigger Loss of Smell
THURSDAY, May 5, 2022 (HealthDay News) -- It has happened to millions during the...
NHS Privatization Tied to Increase in Treatable Mortality
THURSDAY, June 30, 2022 (HealthDay News) -- Outsourcing spending for health care...
